B. Davis

发表

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.

I. Bica, R. Gandhi, C. Birch, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient.

G. Robbins, D. Barouch, W. Faquin, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ocular syphilis among HIV-infected patients: a systematic analysis of the literature

G. Robbins, J. Tucker, Jonathan Z. Li, 2010, Sexually Transmitted Infections.

Severe babesiosis in a patient treated with a tumor necrosis factor α antagonist.

I. Bogoch, D. Hooper, B. Davis, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection.

Victor DeGruttola, Kaveh Maghsoudi, Nesli Basgoz, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection

Todd M. Allen, B. Walker, G. Lauer, 2006, PLoS medicine.

Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

Emily B Hanhauser, M. Altfeld, D. Kuritzkes, 2014, Annals of Internal Medicine.

Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection

E. Rosenberg, M. Altfeld, B. Walker, 2007, PloS one.

Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization

E. Rosenberg, B. Walker, M. Addo, 2003, AIDS.

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Hendrik Streeck, Galit Alter, Nesli Basgoz, 2005, Blood.

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

R. D'Agostino, P. Wilson, J. Meigs, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ocular syphilis among HIV-infected individuals.

G. Robbins, C. Marra, Jonathan Z. Li, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

P. Sax, S. Grinspoon, N. Basgoz, 2000, JAMA.

Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study.

S. Grinspoon, N. Basgoz, B. Davis, 2004, Archives of internal medicine.

High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.

M. Lichterfeld, M. Ferraro, B. Davis, 2010, International journal of antimicrobial agents.

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.

I. Bogoch, B. Davis, N. Venna, 2011, The Journal of infection.

Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.

R. D'Agostino, P. Wilson, J. Meigs, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hydroxyurea for HIV infection.

B. Davis, K. Zachary, 1998, AIDS clinical care.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Faculty Opinions recommendation of Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.

B. Davis, 2005 .